The National Institute for Health and Care Excellence (NICE) is an executive non-departmental public body of the Department of Health and Social Care in the United Kingdom. Established in 1999, NICE provides national guidance and advice to improve health and social care. It evaluates new health technologies for NHS use, considering clinical effectiveness and value for money.
Core Functions of NICE
NICE’s primary responsibilities include:
- Health Technology Appraisal: Evaluating new and existing medicines and treatments within the NHS to ensure they are clinically effective and cost-effective.
nice.org.uk - Clinical Guidelines: Developing evidence-based recommendations for health and care in England and Wales to promote good health and improve the quality of care and services.
nice.org.uk - Quality Standards: Setting benchmarks to help practitioners and commissioners deliver the best care, ensuring value for the taxpayer.
nice.org.uk
Leadership and Key Contacts
As of January 2025, NICE is led by Chief Executive Sam Roberts, who oversees the organization’s strategic initiatives and operations.
Contact Details for NICE
Website: https://www.nice.org.uk/
Postal Address:
National Institute for Health and Care Excellence
2 Redman Place
London, E20 1JQ
United Kingdom
Telephone: +44 (0)300 323 0140
Challenges in Working with NICE
Engaging with NICE involves:
- Understanding Appraisal Processes: Familiarity with NICE’s evaluation methods and criteria is crucial for successful market access.
- Timely and Accurate Submissions: Ensuring that all necessary documentation is complete and submitted promptly to facilitate evaluation processes.
- Demonstrating Cost-Effectiveness: Providing robust evidence that new treatments offer value for money within the NHS framework.
Effective collaboration with NICE can lead to efficient market entry and favorable reimbursement outcomes in the UK.
Opportunities / Solutions with Justin Stindt Consultants
Justin Stindt’s NICE expertise ensures:
- Expert Consultant NICE Submissions: Creating high-quality submissions for health technology appraisals and clinical guideline considerations.
- Market Access NICE Strategies: Developing strategies that align with NICE’s evaluation framework to optimize market access.
- Specialist NICE Processes: Providing insights into NICE’s procedures to enhance compliance and expedite approvals.
Justin Stindt Consultants specializes in assisting clients to effectively engage with NICE’s regulatory environment to achieve successful market access in the UK.
Case Studies
A Pharmaceutical Company’s Success with NICE
Challenge:
A pharmaceutical company sought our assistance to obtain approval and reimbursement for a novel therapy in the UK.
Solution:
We guided them in preparing a comprehensive dossier that addressed NICE’s evaluation criteria.
Outcome:
Our strategic approach led to a positive outcome, enabling the therapy’s inclusion in the NHS formulary.
Need support with NICE market access? Justin Stindt Consultants has the expertise to help you succeed.
Other Key Institutions in Market Access
Global Institutions
- World Health Organization (WHO)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
United States
- Centers for Medicare & Medicaid Services (CMS)
- Academy of Managed Care Pharmacy (AMCP)
- Institute for Clinical and Economic Review (ICER)
France
Germany
- Gemeinsamer Bundesausschuss (G-BA)
- Institute for Quality and Efficiency in Health Care (IQWiG)
- GKV Spitzenverband
United-Kingdom
- National Institute for Health and Care Excellence (NICE)
- Scottish Medicines Consortium (SMC)
- All Wales Medicines Strategy Group (AWMSG)
- National Health Service (NHS)
Italy
Spain
- Spanish Agency of Medicines and Medical Devices (AEMPS)
- Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (DGCF)
- Interministerial Commission on Medicine Prices (CIPM)